By Folasade Akpan Nigeria’s fight against HIV and AIDS may be approaching a turning point with the introduction of Lenacapavir, a long-acting injectable drug that experts say could greatly reduce new infections. Administered twice yearly to HIV-negative individuals at substantial risk, the innovation is being positioned as a critical toolContinue Reading
By Folasade Akpan The Federal Government says it has committed 346 million dollars in co-financing in 2026 to support HIV, tuberculosis and malaria programmes. The Coordinating Minister of Health and Social Welfare, Prof. Muhammad Pate, disclosed this at the national launch of Lenacapavir, a long-acting injectable for HIV prevention.Continue Reading
By Folasade Akpan The Global Fund said on Tuesday in Abuja that it planned to deliver 179,700 doses of Lenacapavir, a long-acting injectable antiretroviral drug, to Nigeria by 2028. The Country Director of the fund, Mr Jean-Thomas Nouboussi, said this at the official unveiling of the long-acting HIV prevention drug.Continue Reading
By Folasade Akpan The Federal Government says Nigeria has received Long-Acting Injectable Lenacapavir for HIV prevention, marking a significant advancement in the country’s efforts to curb new infections. Dr Adebobola Bashorun, Director and National Coordinator, National AIDS, Viral Hepatitis and STIs Control Programme (NASCP) of the Federal Ministry of HealthContinue Reading
By Justina Auta The Federal Government says Nigeria has recorded significant progress toward the introduction and nationwide rollout of Lenacapavir (LEN) as a Pre-Exposure Prophylaxis (PrEP) option to strengthen HIV prevention efforts. This is contained in a statement signed by Mrs Toyin Aderibigbe, Head of Media and Publicity at theContinue Reading
